This device is commercially available for use in select international markets.
A Different Type of Pain Calls for a Different Approach
Chronic pain* is a common condition, affecting almost one in five adults globally.1 But yours is different from most. You have tried the methods that work for other people, but nothing seems to help. This sort of difficult-to-treat isolated chronic pain may start in a lower extremity (foot, knee, hip, and groin) following an injury or surgical procedure and grow worse over time.
Now imagine your life transformed—because today, there is a unique approach to pain like yours: the Axium™ Neurostimulator stimulates the dorsal root ganglion—a cluster of nerve cells in the spine, also called the DRG—that directly targets the area of the body where your pain occurs. This is a new therapy using a well-studied and understood approach for addressing the type of pain you are suffering. DRG stimulation is the next generation in pain relief and it is offered exclusively by St. Jude Medical.
Proof of effective relief for patients like you
The largest neurostimulation clinical trial ever conducted among patients with chronic intractable lower limb pain typically resulting from a previous injury, the ACCURATE Clinical study, showed that with DRG stimulation:3
- 74.2% of DRG patients had treatment success 12 months**3
- 94.5% of the trial participants did not feel stimulation outside of their area of pain3
- DRG patients had an average of 81.4% reduction in their pain at 12 months3
Neurostimulation is not right for everyone. Talk to your doctor to see if neurostimulation may help you manage your pain. It is not advised if you are unable to operate the system or do not receive effective pain relief during the evaluation period.
The placement of a neurostimulation system requires surgery, which exposes you to certain risks. Complications related to the procedure and/or device include infection, swelling, bruising, undesirable changes in stimulation and loss of strength or use in an affected limb or muscle group (e.g., paralysis). Additional risks such as undesirable changes in stimulation may occur over time. Be sure to talk to your doctor about all the possible risks associated with neurostimulation.
See important safety information.